Literature DB >> 15483804

Patient satisfaction and functional status after aseptic versus septic revision total knee arthroplasty using the PROSTALAC articulating spacer.

R M Dominic Meek1, David Dunlop, Donald S Garbuz, Robert McGraw, Nelson V Greidanus, Bassam A Masri.   

Abstract

This study compared the functional results of an articulating antibiotic spacer for 2-stage revision knee arthroplasty for infection, to the functional results of aseptic revision. One hundred twenty-five patients who underwent revision of total knee arthroplasty for infection and aseptic loosening were identified. All of the patients with infection were treated with the PROSTALAC system (DePuy). At a minimum 2-year follow-up, WOMAC, Oxford-12, SF-12, patient satisfaction data, Harris Hip Score knee scores, and range of motion were assessed. The 2 cohorts (4 deaths in total, leaving 54 septic, 57 aseptic) were equivalent for age, gender, and comorbidity scores. At a mean of 41 months, none of the outcomes were significantly worse for the septic group, which had 2 recurrences of infection (4%). The satisfactory functional results of the PROSTALAC system may be related to the design features.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483804     DOI: 10.1016/j.arth.2004.06.028

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  16 in total

Review 1.  Two-stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one-stage or two-stage revision with static spacers.

Authors:  C L Romanò; L Gala; N Logoluso; D Romanò; L Drago
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-01-21       Impact factor: 4.342

2.  The use of spacers (static and mobile) in infection knee arthroplasty.

Authors:  Luca Mazzucchelli; Federica Rosso; Antongiulio Marmotti; Davide Edoardo Bonasia; Matteo Bruzzone; Roberto Rossi
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

3.  Durable infection control and function with the PROSTALAC spacer in two-stage revision for infected knee arthroplasty.

Authors:  Christopher R Gooding; Bassam A Masri; Clive P Duncan; Nelson V Greidanus; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

4.  [Dynamic versus static cement spacer in periprosthetic knee infection: A meta-analysis].

Authors:  Mustafa Citak; Musa Citak; Daniel Kendoff
Journal:  Orthopade       Date:  2015-08       Impact factor: 1.087

5.  Prevention of surgical site infections in bone and joint procedures.

Authors:  Ralf-Peter Vonberg; Petra Gastmeier
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

6.  Periprosthetic joint infection--effect on quality of life.

Authors:  Peter Helwig; Julia Morlock; Michael Oberst; Oliver Hauschild; Johannes Hübner; Johannes Borde; Norbert P Südkamp; Lukas Konstantinidis
Journal:  Int Orthop       Date:  2014-01-07       Impact factor: 3.075

7.  Two-stage treatment of infected total knee arthroplasty: two to thirteen year experience using an articulating preformed spacer.

Authors:  Claudio Carlo Castelli; Valerio Gotti; Roberto Ferrari
Journal:  Int Orthop       Date:  2014-01-26       Impact factor: 3.075

Review 8.  Painful prosthesis: approaching the patient with persistent pain following total hip and knee arthroplasty.

Authors:  Prisco Piscitelli; Giovanni Iolascon; Massimo Innocenti; Roberto Civinini; Alessandro Rubinacci; Maurizio Muratore; Michele D'Arienzo; Paolo Tranquilli Leali; Anna Maria Carossino; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2013-05

9.  [Treatment of infected total knee arthroplasty. 2-5-year results following two-stage reimplantation].

Authors:  M Pietsch; C Wenisch; S Hofmann
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

Review 10.  Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach.

Authors:  Esa Jämsen; Ioannis Stogiannidis; Antti Malmivaara; Jorma Pajamäki; Timo Puolakka; Yrjö T Konttinen
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.